Aspects of metabolic changes in first-episode drug-naïve schizophrenic patients

Marat G Uzbekov1, Eduard Misionzhnik1, Isaak Gurovich2

  • 11 Department of Brain Pathology, Research Institute of Psychiatry, Moscow, Russia.

Acta Neuropsychiatrica
|October 8, 2014
PubMed
Abstract

Insights

First-episode drug-naïve schizophrenic patients show altered metabolism and increased endogenous intoxication. These findings suggest schizophrenia

Area of Science:

  • Biochemistry
  • Psychiatry
  • Metabolic Disorders

Background:

  • Schizophrenia is a complex psychiatric disorder with debated underlying biochemical mechanisms.
  • Early stages of schizophrenia may present distinct metabolic profiles compared to chronic forms.

Purpose of the Study:

  • To investigate metabolic parameters and endogenous intoxication in first-episode drug-naïve schizophrenia (FES).
  • To explore if FES represents an initial stage of the pathological biochemical status seen in chronic schizophrenia.

Main Methods:

  • Assessed platelet monoamine oxidase (MAO) and serum semicarbazide-sensitive amine oxidase (SSAO) activities.
  • Measured serum middle-mass endotoxic molecules (MMEM) and malondialdehyde, alongside albumin functional parameters.
  • Included 26 FES patients and 15 healthy controls.

Main Results:

  • FES patients exhibited significantly increased MAO activity (99%) and MMEM concentration (124%), and decreased SSAO activity (26%) versus controls.
  • Regression analysis revealed significant relationships between MAO, SSAO, MMEM, and Positive and Negative Syndrome Scale (PANNS) scores.
  • Factor analysis grouped MAO and SSAO together, and MMEM with albumin parameters.

Conclusions:

  • FES patients display a distinct metabolic profile characterized by altered enzyme activities and increased endotoxemia.
  • The observed metabolic disturbances in FES suggest it is a precursor stage to the established pathological state in chronic schizophrenia.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
693
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
440
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
946